Water-Intrusion Test Integration - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Water-Intrusion Test Integration
The authors describe the operational qualification of test accuracy with regard to temperature drift using a thermal-compensation algorithm on several freeze dryers.


Pharmaceutical Technology
pp. 64-70

The sterilizing grade filter on a freeze dryer is a fundamental element for maintaining sterility throughout the process of lyophilization. According to Annex 1 in the European Guidelines, the integrity of critical gas filters should be confirmed after use (1). Risk analysis could also confirm the need for testing before use because of the value of a particular product.

The water intrusion test (WIT) for hydrophobic PTFE membrane cartridges enables in situ integrity testing without the interference of contaminative wetting media (e.g., alcohol) and obviates the need for downstream manipulation. WIT measures the decay rate of a pressure level imposed upon a hydrophobic membrane surrounded by water on the upstream side. Its dependability derives from the demonstrated correlation of the test values to organism retention levels in accordance with the HIMA ASTM F-838-05 guideline (2).

WIT has been demonstrated to apply to mono membranes of expanded PTFE since 1991. It may or may not extend to other constructions. Importantly, WIT reflects the hydrophobicity of the filter and thus assesses the suitability of air filters for reuse in equipment, such as freeze dryers, autoclaves, and all other venting applications.

Temperature drift may have a significant effect on the integrity test value and may result in false conformity or false non-conformity test results. To avoid this thermal impact, a thermal compensation algorithm can be used for applications (e.g., freeze dryers and autoclaves) on which an integrated WIT-system has been implemented.

This article will describe the operational qualification of the test accuracy using the thermal-compensation algorithm. Sartorius Stedim and the Global Technical Service for Secondary Technologies of GSK Biologicals qualified the test jointly on several freeze dryers (IMA Life).

Materials and methods

The following equipment and materials were used: freeze dryers (LMX33, IMA Life), hydrophobic sterilizing grade filter (Sartofluor 0.2 µm, 10 in., Sartorius), cartridge dummy (hand-made from filter cartridge components), stainless steel filter housing (Sartorius), Nitra pneumatic 4-mm diameter tubing (Nitra, AutomationDirect), needle valve for water (Swagelok), high precision scales (Sartorius Stedim), electro heating ribbon (Tibtech), and a sports timer (EA Combs).

For all accuracy trials, a standard WIT was launched from the supervisory control and data acquisition (SCADA) system on the freeze dryer using the filter dummy. The WIT involved the following steps:

  • Filling the water vessel
  • Filling the stainless steel housing with test water
  • Compacting the headspace volume
  • 10-min stabilization
  • 10-min measurement phase with removal of 3–4 g of water using high-precision scales and simultaneous heating of the headspace, if appropriate
  • Draining.

All test parameters were visualized on SCADA and printed.

For the drying qualification, a real membrane cartridge was used. The detailed information in this article will be restricted to accuracy qualification and temperature-drift correction.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here